跳至主要内容
临床试验/TCTR20210216002
TCTR20210216002已完成2 期

Peri-articular with Peri-Hamstring injection for pain control after Anterior Cruciate Ligament reconstruction: Bupivacaine/Ketorolac/Adrenaline versus Placebo, A randomized controlled trial, double-blinded study

/A0 个研究点目标入组 40 人开始时间: 2021年2月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

Peri-articular with peri-hamstring MCD injection can effectively reduce short-term postoperative pain and morphine consumption following arthroscopic ACL reconstruction with a hamstring graft.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • 1. Patients diagnosed ACL injury that have to be performed ACLR (elective case)
  • 2. Age 18 to 50 years
  • 3. Normal Conciousness
  • 4. Volunteer

排除标准

  • 1. ASA classification more than 3
  • 2. Have history drug allergy (Bupivacaine, NSAIDs, Opioid)
  • 3. Have history of UGIB
  • 4. Chronic Kidney Disease stage 3 or GFR < 60 ml/min/1.73 m2
  • 5. Underlying disease Ishemic Heart Disease, Cardio Vascular Disease, Platelet disorder. Coagulopathy
  • 6. Usage of anti-coagulant drug
  • 7. Have contraindication for Spinal Anesthesia or neurologic disorder

研究者

发起方
/A

相似试验

Peri-articular multimodal cocktail drug injection... | 临床试验